Department of Medical Genetics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India; School of Biotechnology, KIIT University, Bhubaneswar, India.
Hum Immunol. 2013 Oct;74(10):1339-45. doi: 10.1016/j.humimm.2013.06.015. Epub 2013 Jun 15.
NK cell function is regulated by cell surface inhibitory and activating receptors including the C-type lectin receptors and Killer Immunoglobulin-like receptors (KIR). The effect of immune modulating cytokines produced by NK cells in the pathogenesis of end stage renal disease (ESRD) remained intriguing. In this regard the present study assesses the combinatorial association of KIR gene content and KIR receptor-HLA ligand in the North Indian ESRD patients.
KIR gene polymorphism as a susceptible marker in ESRD among 512 patients and 512 ethnically matched controls was analyzed. PCR-SSP based genotyping for KIR gene content and HLA-A, B, C typing was carried out.
Significant difference in frequencies of KIR2DS1-HLA-C2 (p≤0.0001, OR=1.98, CI=1.50-2.61), KIR2DS2-HLAC1 (p≤0.0001, OR=1.87, CI=1.42-2.46), KIR3DS1-HLA-Bw4 (p=0.0038, OR=1.46, CI=1.13-1.88) combinations for ESRD was found. In the combinatorial analysis Bw4(+)/3DL1(-)/3DS1(+) (p≤0.0001, OR=4.90, CI=2.75-8.71) and C1(+)/2DL2(-)/2DL3(-)/2DS2(+)/2DS3(+) (p=0.0037, OR=2.50, CI=1.35-4.63) showed risk association. KIR3DS1 was observed to be susceptible for all four primary kidney disease groups.
NK cell de-regulation due to HLA ligand binding KIR receptors may be involved in the patho-physiology of ESRD. Upon analyzing the data in this context it was found that C2/C2 donor might improve the clinical outcome of patients having C2 ligands.
NK 细胞的功能受细胞表面抑制和激活受体的调节,包括 C 型凝集素受体和杀伤免疫球蛋白样受体(KIR)。NK 细胞产生的免疫调节细胞因子在终末期肾病(ESRD)发病机制中的作用仍然很有趣。在这方面,本研究评估了 KIR 基因含量和 KIR 受体-HLA 配体在北印度 ESRD 患者中的组合关联。
在 512 名患者和 512 名种族匹配的对照中,分析了 KIR 基因多态性作为 ESRD 的易感标志物。进行了基于 PCR-SSP 的 KIR 基因含量和 HLA-A、B、C 型基因分型。
发现 ESRD 患者中 KIR2DS1-HLA-C2(p≤0.0001,OR=1.98,CI=1.50-2.61)、KIR2DS2-HLAC1(p≤0.0001,OR=1.87,CI=1.42-2.46)、KIR3DS1-HLA-Bw4(p=0.0038,OR=1.46,CI=1.13-1.88)组合的频率存在显著差异。在组合分析中,Bw4(+)/3DL1(-)/3DS1(+)(p≤0.0001,OR=4.90,CI=2.75-8.71)和 C1(+)/2DL2(-)/2DL3(-)/2DS2(+)/2DS3(+)(p=0.0037,OR=2.50,CI=1.35-4.63)显示出风险关联。观察到 KIR3DS1 对所有四种原发性肾病组均易感。
由于 HLA 配体结合 KIR 受体导致的 NK 细胞失调可能参与了 ESRD 的病理生理学过程。在这种情况下分析数据时,发现 C2/C2 供体可能会改善具有 C2 配体的患者的临床结局。